TipRanks
Go Ultimate55% OFF

Argonaut Resources (ORP) AI Stock Analysis

0 Followers
AU:ORP

Argonaut Resources

(ASX:ORP)

Select Model
Rating:46Neutral
Price Target:AUD 0.07â–²(2.78% Upside)
Action:reiterated
Date:11/04/26

The score is weighed down primarily by a pre-revenue, loss-making and cash-burning financial profile, despite a comparatively strong, low-debt balance sheet. Technicals add further pressure with price trading below key moving averages and negative MACD, while valuation provides limited support due to negative earnings and no dividend data.

Positive Factors
Very Low LeverageThe sharp reduction in debt leaves Argonaut with limited leverage pressure and a stronger capacity to preserve capital while advancing its exploration strategy. Low debt also reduces financing strain and gives the company greater flexibility if operating conditions or funding needs change.
Negative Factors
No Commercial RevenueThe absence of revenue means Argonaut has not yet demonstrated commercial traction or an operating model capable of funding itself. Until exploration assets produce a revenue stream, the company’s longer-term prospects remain dependent on project advancement and access to additional capital.

Argonaut Resources (ORP) vs. iShares MSCI Australia ETF (EWA)

-50%0%50%100%150%200%AU:ORP+38.46%EWA+12.22%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 28.17M
Dividend Yield
―
Average Volume (3M)
471.66K
Price to Earnings (P/E)
-12.4
Beta (1Y)
1.43
Revenue Growth
―
EPS Growth
53.60%
Country
Australia
Employees
6
Sector
Basic Materials
Sector Strength
61
Industry
Industrial Materials

Argonaut Resources Business Overview & Revenue Model

Company Description

Orpheus Uranium Limited is an Australian entity, based in Unley, that engages in the discovery and advancement of various mineral assets via its subsidiaries. Founded in 1985, the company primarily targets deposits of uranium, copper, gold, nickel, l...

Argonaut Resources Financial Statement Overview

Summary

High-risk, pre-revenue profile: no revenue in FY2025–FY2026 and profitability remains deeply negative despite a narrowing net loss (-2.81M to -1.80M). The balance sheet is a key support with very low leverage and higher equity, but ongoing negative operating/free cash flow indicates continued cash burn and potential future funding needs.

Income Statement

18Very Negative

Balance Sheet

72Positive

Cash Flow

33Negative
Financial statement breakdown
BreakdownTTMJun 2025Jun 2024
Income Statement
Total Revenue000
Gross Profit-77.17K-77.17K-58.21K
EBITDA-2.21M-2.11M-2.74M
Net Income-1.80M-1.80M-2.81M
Balance Sheet
Total Assets10.74M10.74M7.67M
Cash, Cash Equivalents and Short-Term Investments4.98M4.98M4.18M
Total Debt21.59K21.59K81.78K
Total Liabilities782.51K782.51K234.19K
Stockholders Equity9.96M9.96M7.44M
Cash Flow
Free Cash Flow-1.99M-1.99M-1.54M
Operating Cash Flow-1.89M-1.89M-1.53M
Investing Cash Flow-1.44M-1.44M-683.67K
Financing Cash Flow4.14M4.14M2.70M

Argonaut Resources Technical Analysis

Technical Analysis SentimentNegative
Last Price0.07

Price Trends

50DMA0.11Negative
100DMA0.10Negative
200DMA0.08Negative

Market Momentum

MACD-0.01Negative
RSI35.71Neutral
STOCH12.28Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ORP, the sentiment is Negative. The current price of 0.07 is below the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.11, and below the 200-day MA of 0.08, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 35.71 is Neutral, neither overbought nor oversold. The STOCH value of 12.28 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ORP.

Argonaut Resources Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

AU:ORP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
AU:ORPAU:ORP46NeutralAUD 33.26M-12.41-21.42%――53.60%
AU:SGAAU:SGA45NeutralAUD 15.65M-4.31-10.76%――49.10%
AU:TSLAU:TSL45NeutralAUD 14.44M-12.00-8.30%――-40.00%
AU:REEAU:REE42NeutralAUD 10.95M-2.63-83.24%――-9.30%
AU:WINAU:WIN38UnderperformAUD 17.18M-3.89-21.01%――93.65%
AU:OD6AU:OD637UnderperformAUD 29.78M-2.88-51.72%――-37.56%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%100%150%AU:ORPAU:TSLAU:WINAU:REEAU:SGAAU:OD6Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:ORP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:ORPArgonaut Resources N.L.0.070.0228.57%
AU:TSLTitanium Sands Ltd.0.010.000.00%
AU:WINWidgie Nickel Limited0.02-0.02-47.50%
AU:REERareX Limited0.01-0.02-70.59%
AU:SGASarytogan Graphite Limited0.06-0.05-46.36%
AU:OD6OD6 Metals Ltd.0.080.001.30%

Argonaut Resources Corporate Events

Orpheus Uranium Outlines Position in Corporate Presentation

Nov 2, 2026

Orpheus Uranium Limited is an Australian uranium exploration company focused on developing resources for the energy market. Its corporate presentation provides background on its exploration activities and associated risks, but does not report a new o...

Orpheus Issues 4.6 Million Shares After Option Exercises

Nov 2, 2026

Orpheus Uranium issued 4,611,691 fully paid ordinary shares following the exercise of options. The company confirmed that the issue complied with applicable corporate reporting and disclosure requirements, increasing its issued share capital while pr...

Orpheus Uranium Applies to Quote 4.61 Million Shares

Nov 2, 2026

Orpheus Uranium Limited is applying to quote 4,611,691 fully paid ordinary shares on the ASX under the ticker ORP. The securities have an issue date of November 2, 2026, increasing the company’s quoted ordinary share capital, although the relea...

Orpheus Uranium Director Purchases 200,000 Shares

Nov 1, 2026

Orpheus Uranium Limited is a resources company focused on uranium, although the release does not detail its products, projects or market focus. Director Simon Mitchell, together with the Mitchell Super Fund, acquired 200,000 ordinary shares on market...

Orpheus Uranium Secures Oobagooma Project, Strengthening Western Australian Portfolio

Oct 23, 2026

Orpheus Uranium has completed the acquisition of the Oobagooma Uranium Project in Western Australia’s Canning Basin, adding a significant asset to its uranium exploration portfolio. The transaction, undertaken with Elevate Uranium, includes the...

Orpheus Uranium Issues Shares to Acquire New Exploration Projects

Oct 23, 2026

Orpheus Uranium Limited has issued 22,500,000 fully paid ordinary shares as consideration for the acquisition of uranium exploration projects, underscoring its commitment to expanding its portfolio of early-stage assets in mining-friendly Australian...

Orpheus Uranium Seeks ASX Quotation for 20 Million New Shares

Oct 23, 2026

Orpheus Uranium Limited has lodged an application with the ASX for quotation of 20,000,000 ordinary fully paid shares, to be issued on October 23, 2026. The move expands the company’s listed capital base, potentially enhancing liquidity in its...

Orpheus Uranium Seeks ASX Quotation for Shares Linked to Marree Licence Acquisition

Oct 23, 2026

Orpheus Uranium Limited has applied for quotation of 2,500,000 new ordinary fully paid shares on the ASX. The securities are being issued in connection with the acquisition of exploration licences contiguous with and adjacent to the company’s e...

Orpheus Uranium advances drilling and expands district-scale tenure

Oct 22, 2026

During the quarter to 30 September 2026, Orpheus Uranium advanced its portfolio with a maiden drilling program at the Frome Project, following extensive geological work and permitting. The company also executed a strategic acquisition and lodged regi...

Orpheus Uranium Boosts Cash Reserves With Equity Raising as Exploration Spend Climbs

Oct 22, 2026

Orpheus Uranium reported a cash outflow from operating activities of A$0.894 million for the quarter ended 30 September 2026, driven mainly by staff, administration and business development costs. With no receipts from customers and operating expendi...

Orpheus Uranium Wins Strong Shareholder Backing at AGM

Oct 22, 2026

Shareholders of Orpheus Uranium Limited overwhelmingly endorsed all resolutions at the company’s annual general meeting on 22 October 2026, including adoption of the remuneration report and the re-election of director Simon Mitchell. Investors...

Orpheus Uranium Defines Key Redox Corridors at Frome Project

Oct 21, 2026

Orpheus Uranium has completed its first drilling program at the Erudina Uranium Prospect within the Frome Project in South Australia, targeting sandstone-hosted uranium in the Callabonna Sub-Basin. The campaign drilled 18 rotary mud holes for 3,600 m...

Orpheus Uranium outlines South Australian exploration strategy and risk framework

Oct 8, 2026

Orpheus Uranium Limited has released an investor presentation outlining its strategy to build a geologically relevant uranium exploration portfolio in South Australia. The document, prepared in October 2026, emphasises that it is informational in nat...

Orpheus Uranium Calls 2026 AGM to Approve Capital and Governance Resolutions

Sep 21, 2026

Orpheus Uranium Limited has convened its 2026 Annual General Meeting for 22 October in Adelaide, specifying that shareholders must attend in person as no online participation will be available. The meeting will table the company’s annual report...

Orpheus Uranium Details Cash Position and Asset Deals in Corporate Update

Sep 17, 2026

Orpheus Uranium has outlined its current corporate position in a September 2026 presentation, highlighting a cash balance of $4.96 million and liquid investments of $1.05 million, including 3.75 million shares in Prospect Resources. The company also...

Orpheus Uranium Releases 2025 Annual Report

Aug 31, 2026

Orpheus Uranium Limited has released its 2025 annual report, providing shareholders with a comprehensive overview of its financial performance and corporate governance for the year. The report includes audited financial statements, directors’ c...

Orpheus Uranium details capital position and portfolio moves in new corporate presentation

Aug 25, 2026

Orpheus Uranium Limited, an ASX-listed uranium exploration company, is positioning itself within Australia’s energy resources sector, leveraging its technical team and strategic investments to advance uranium projects. The firm’s operatio...

Orpheus Uranium expands Marree project with new exploration licences

Aug 18, 2026

Orpheus Uranium has secured three new exploration licences, EL 7144, EL 7145 and EL 7146, for its wholly owned subsidiary Trachre Pty Ltd, expanding the footprint and continuity of its Marree Uranium Project in South Australia. The licences form part...

Orpheus Uranium to Expand Marree Footprint with Strategic Tenement Deal

Aug 13, 2026

Orpheus Uranium has executed a sale agreement with Adavale Resources to acquire up to seven exploration licences covering about 2,513 square kilometres contiguous with its existing Marree Uranium Project in South Australia. The deal will materially e...

Adavale Sells Marree Uranium Assets to Refocus on Parkes Gold-Copper Project

Aug 13, 2026

Adavale Resources has executed a sale agreement with Orpheus Uranium for its Marree Embayment uranium portfolio, comprising seven granted exploration licences. The deal delivers $650,000 in cash and 5 million Orpheus shares, giving Adavale a 1.25% st...

Orpheus Uranium expands capital base with new share issue to fund exploration

Aug 4, 2026

Orpheus Uranium Limited has issued 47,222,222 fully paid ordinary shares at $0.09 per share, expanding its share capital through a placement conducted without a prospectus under Section 708A of the Corporations Act. The company confirmed ongoing comp...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 04, 2026